Hidden PCOS Dangers: Early Heart Disease Risk

Polycystic Ovary Syndrome (PCOS), a hormonal imbalance affecting approximately one in 10 Canadian women, faces significant under-diagnosis and under-recognition. This condition is linked to serious health complications, including a 20-40% increased lifetime risk of negative health outcomes. Specifically, women with PCOS are two to three times more likely to have obesity, dyslipidemia, and Type 2 diabetes. Most critically, their risk of cardiovascular disease, including heart failure and stroke, is 30-50% higher and occurs three to four years earlier than average.

Despite being diagnosed nearly a century ago, there is no single test for PCOS, contributing to diagnostic delays that can last months or years. Women often report their concerns being dismissed by healthcare providers. Effective management, including lifestyle changes and medical treatment, can help mitigate risks. Recent global efforts, such as the International PCOS Guideline published in 2023 and Alberta's clinical pathway, aim to improve care and advocate for affected women. Research labs like EMBRACE at the University of Calgary are actively working with patient groups to develop better diagnostic and management tools.